After the identification of AD-related plaque (amyloid beta) and tangle (tau) pathological conditions, a number of studies have been conducted to understand disease progression, develop disease prognosis, and apply therapeutics to overcome dementia based on the pathology of AD. The gene discussed is MAPT; the disease is Alzheimer disease.